Renal function and outcomes in acute coronary syndrome: impact of clopidogrel (Q44669077)

5 December 2017

title

Renal function and outcomes in acute coronary syndrome: impact of clopidogrel (English)

1 reference

5 December 2017

1 reference

acute coronary syndrome

1 reference

Marcello Tonelli

2

0 references

Salim Yusuf

8

object named as

Salim Yusuf

1 reference

5 December 2017

Mátyás Keltai

1

1 reference

5 December 2017

Johannes F E Mann

3

1 reference

5 December 2017

Eva Sitkei

4

1 reference

5 December 2017

Basil S Lewis

5

1 reference

5 December 2017

Steven Hawken

6

1 reference

5 December 2017

Shamir R Mehta

7

1 reference

5 December 2017

CURE Trial Investigators

9

1 reference

5 December 2017

publication date

1 April 2007

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

5 December 2017

published in

1 reference

5 December 2017

volume

14

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

312-318

1 reference

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Acute myocardial infarction and renal dysfunction: a high-risk combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Aging, progenitor cell exhaustion, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

Clopidogrel Activities in Patients with Renal Function Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/01.HJR.0000220582.19516.A6

10.1097/01.HJR.0000220582.19516.A6

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference